Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies
Daphne T. Adelman, Dirk Van Genechten, Clémentine M. Megret, et al.
Advances in Therapy (2019) Vol. 36, Iss. 12, pp. 3409-3423
Open Access | Times Cited: 16

Showing 16 citing articles:

Journey to the Market: The Evolution of Biodegradable Drug Delivery Systems
Minze Zhu, Andrew K. Whittaker, Felicity Y. Han, et al.
Applied Sciences (2022) Vol. 12, Iss. 2, pp. 935-935
Open Access | Times Cited: 22
PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly
Dermot O’Toole, Pamela L. Kunz, Susan M. Webb, et al.
Advances in Therapy (2022) Vol. 40, Iss. 2, pp. 671-690
Open Access | Times Cited: 13
Guidelines on diagnostics and treatment of acromegaly (draft)
Elena Przhiyalkovskaya, Н. Г. Мокрышева, Е. А. Трошина, et al.
Obesity and metabolism (2024) Vol. 21, Iss. 2, pp. 215-249
Open Access | Times Cited: 2
Evaluation of Nurse Preferences Between the Lanreotide Autogel New Syringe and the Octreotide Long-Acting Release Syringe: An International Simulated-Use Study (PRESTO)
Daphne T. Adelman, Xuan-Mai Truong Thanh, Marion Feuilly, et al.
Advances in Therapy (2020) Vol. 37, Iss. 4, pp. 1608-1619
Open Access | Times Cited: 20
A New Approach to Supramolecular Structure Determination in Pharmaceutical Preparation of Self-Assembling Peptides: A Case Study of Lanreotide Autogel
Manuela Grimaldi, Angelo Santoro, Michela Buonocore, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 681-681
Open Access | Times Cited: 10
Patient and Healthcare Provider Perspectives of First-Generation Somatostatin Analogs in the Management of Neuroendocrine Tumors and Acromegaly: A Systematic Literature Review
David Cella, Jennifer Evans, Marion Feuilly, et al.
Advances in Therapy (2021) Vol. 38, Iss. 2, pp. 969-993
Open Access | Times Cited: 14
New and emerging pharmacological treatment options for acromegaly
Ximene Antunes, Leandro Kasuki, Mônica R. Gadelha
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 12, pp. 1615-1623
Closed Access | Times Cited: 13
Customer-centric product presentations for monoclonal antibodies
Beate Bittner
AAPS Open (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: Results from the international HomeLAN survey
Jorge Hernando, Teodora Kolarova, Chris Verslype, et al.
Journal of Neuroendocrinology (2023) Vol. 35, Iss. 6
Open Access | Times Cited: 3
An international simulated-use study to assess nurses’ preferences between two lanreotide syringes for patients with neuroendocrine tumours or acromegaly (PRESTO 3)
Diego Ferone, Wendy Martin, Jesse W. Williams, et al.
Journal of Endocrinological Investigation (2023) Vol. 47, Iss. 2, pp. 421-432
Open Access | Times Cited: 3
Evaluation of the Octreotide Acetate Pen Injector and its Instructions for Use in a Formative Human Factors Study
Anthony D. Andre, Nicholas Squittieri, Satyashodhan Patil
Advances in Therapy (2021) Vol. 38, Iss. 6, pp. 3129-3142
Open Access | Times Cited: 4
Correction to: Co-Creation of a Lanreotide Autogel/Depot Syringe for the Treatment of Acromegaly and Neuroendocrine Tumours Through Collaborative Human Factor Studies
Daphne T. Adelman, Dirk Van Genechten, Clémentine M. Megret, et al.
Advances in Therapy (2020) Vol. 37, Iss. 2, pp. 975-976
Open Access | Times Cited: 1
Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine Tumours
Jens Otto Lunde Jørgensen, Wouter W. de Herder, Wendy A. Martin, et al.
Advances in Therapy (2023) Vol. 40, Iss. 10, pp. 4675-4688
Closed Access
Science Without Borders – Can Translation Tools Bridge the Language Gap?
Claire Beeby, Eleanor J Raynsford, C. C. Pollitt
AMWA Journal (2023) Vol. 38, Iss. 3
Open Access
Targeted treatment with somatostatin analogues: widening horizons of clinical practice
Vyacheslav Pronin, М. Б. Анциферов, T. M. Alexeeva, et al.
Almanac of Clinical Medicine (2022) Vol. 50, Iss. 3, pp. 196-204
Open Access
Modern realities and prospects of drug treatment of acromegaly
Vyacheslav Pronin, М. Б. Анциферов, T.M. Alekseeva, et al.
Endocrinology News Opinions Training (2022) Vol. 11, Iss. 3, pp. 27-36
Open Access
Page 1

Scroll to top